Surgical Management of the Patients with Liver Metastases of Pancreatic Neuroendocrine Tumors

#835

Introduction: Most pancreatic neuroendocrine tumors (PNET) grow slowly but around 60% of the patients have distant metastases. Although new drugs have recently emerged, surgical resection is still one of the key modalities for curing the tumor.

Aim(s): To elucidate the tumor categories which get the most benefit from surgical resection of the metastases, we examine the efficacy of the surgical resection of the PNET distant metastases on survival.

Materials and methods: From 1992 to 2012, 121 PNET patients were treated at our hospital. Of these, there were 16 patients who had recurrences after curative resection and 22 patients with distant metastasis at their first admission. We analyzed the progression-free survival as well as overall survival of the resected patients.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Masui T, Takaori K, Mizumoto M, Iwanaga Y, Kawaguchi M,

Keywords: PNET, distant metastases, resection,